Anti-ADAMTS13 IgG Autoantibodies Present in Healthy Individuals Share Linear Epitopes with Those in Patients with Thrombotic Thrombocytopenic Purpura

Overview

Journal Haematologica

Specialty Hematology

Date 2014 Feb 18

PMID 24532042

Citations 13

Authors

Rana Grillberger

Veronica C Casina

Peter L Turecek

X Long Zheng

Hanspeter Rottensteiner

Friedrich Scheiflinger

Affiliations

Soon will be listed here.

Citing Articles

Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.

Laghmouchi A, Graca N, Voorberg J Front Immunol. 2021; 12:757192.

PMID: 34858410 PMC: 8631936. DOI: 10.3389/fimmu.2021.757192.

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.

Sukumar S, Lammle B, Cataland S J Clin Med. 2021; 10(3).

PMID: 33540569 PMC: 7867179. DOI: 10.3390/jcm10030536.

Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

Muia J, Zhu J, Greco S, Vanhoorelbeke K, Gupta G, Westfield L Blood. 2019; 133(17):1899-1908.

PMID: 30700419 PMC: 6484387. DOI: 10.1182/blood-2018-11-886275.

Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients.

Schelpe A, Roose E, Joly B, Pareyn I, Mancini I, Biganzoli M Haematologica. 2018; 104(6):1268-1276.

PMID: 30523052 PMC: 6545854. DOI: 10.3324/haematol.2018.205666.

Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura.

Staley E, Cao W, Pham H, Kim C, Kocher N, Zheng L Haematologica. 2018; 104(1):166-175.

PMID: 30171022 PMC: 6312039. DOI: 10.3324/haematol.2018.198275.

References

Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K . Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A. 2008; 105(28):9727-32. PMC: 2474524. DOI: 10.1073/pnas.0803644105. View

Shukla N, Salunke D, Balakrishna R, Mutz C, Malladi S, David S . Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. PLoS One. 2012; 7(8):e43612. PMC: 3429503. DOI: 10.1371/journal.pone.0043612. View

Igari A, Nakagawa T, Moriki T, Yamaguchi Y, Matsumoto M, Fujimura Y . Identification of epitopes on ADAMTS13 recognized by a panel of monoclonal antibodies with functional or non-functional effects on catalytic activity. Thromb Res. 2012; 130(3):e79-83. DOI: 10.1016/j.thromres.2012.06.006. View

Luken B, Kaijen P, Turenhout E, Kremer Hovinga J, van Mourik J, Fijnheer R . Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost. 2006; 4(11):2355-64. DOI: 10.1111/j.1538-7836.2006.02164.x. View

Rieger M, Mannucci P, Kremer Hovinga J, Herzog A, Gerstenbauer G, Konetschny C . ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood. 2005; 106(4):1262-7. DOI: 10.1182/blood-2004-11-4490. View

Zheng X, Wu H, Shang D, Falls E, Skipwith C, Cataland S . Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010; 95(9):1555-62. PMC: 2930958. DOI: 10.3324/haematol.2009.019299. View

Jian C, Xiao J, Gong L, Skipwith C, Jin S, Kwaan H . Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2012; 119(16):3836-43. PMC: 3335387. DOI: 10.1182/blood-2011-12-399501. View

Olson S, Arbogast C, Baker T, Owshalimpur D, Oliver D, Abbott K . Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011; 22(10):1946-52. PMC: 3279953. DOI: 10.1681/ASN.2010090928. View

Luken B, Turenhout E, Kaijen P, Greuter M, Pos W, van Mourik J . Amino acid regions 572-579 and 657-666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP. Thromb Haemost. 2006; 96(3):295-301. DOI: 10.1160/TH06-03-0135. View

10.

Yang R, Cui Z, Hellmark T, Segelmark M, Zhao M, Wang H . Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol. 2007; 124(2):207-12. DOI: 10.1016/j.clim.2007.05.001. View

11.

Roth A, Ooi J, Hess J, van Timmeren M, Berg E, Poulton C . Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013; 123(4):1773-83. PMC: 3613913. DOI: 10.1172/JCI65292. View

12.

Pos W, Crawley J, Fijnheer R, Voorberg J, Lane D, Luken B . An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF. Blood. 2009; 115(8):1640-9. PMC: 2830766. DOI: 10.1182/blood-2009-06-229203. View

13.

Yamaguchi Y, Moriki T, Igari A, Nakagawa T, Wada H, Matsumoto M . Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura. Thromb Res. 2011; 128(2):169-73. DOI: 10.1016/j.thromres.2011.03.010. View

14.

Pos W, Sorvillo N, Fijnheer R, Feys H, Kaijen P, Vidarsson G . Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain. Haematologica. 2011; 96(11):1670-7. PMC: 3208685. DOI: 10.3324/haematol.2010.036327. View

15.

Klaus C, Plaimauer B, Studt J, Dorner F, Lammle B, Mannucci P . Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura. Blood. 2004; 103(12):4514-9. DOI: 10.1182/blood-2003-12-4165. View

16.

Crawley J, de Groot R, Xiang Y, Luken B, Lane D . Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 2011; 118(12):3212-21. PMC: 3179391. DOI: 10.1182/blood-2011-02-306597. View

17.

Coppo P, Busson M, Veyradier A, Wynckel A, Poullin P, Azoulay E . HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians. J Thromb Haemost. 2010; 8(4):856-9. DOI: 10.1111/j.1538-7836.2010.03772.x. View

18.

Ueki A, Isozaki Y, Tomokuni A, Hatayama T, Ueki H, Kusaka M . Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol. 2002; 129(3):556-61. PMC: 1906472. DOI: 10.1046/j.1365-2249.2002.01939.x. View

19.

Moriki T, Maruyama I, Igari A, Ikeda Y, Murata M . Identification of ADAMTS13 peptide sequences binding to von Willebrand factor. Biochem Biophys Res Commun. 2009; 391(1):783-8. DOI: 10.1016/j.bbrc.2009.11.138. View